You searched for "outpatient"
Recent developments in bladder cancer – MIBC
This article takes a look back over recent years at new innovations and developments relating to muscle-invasive bladder cancer (MIBC) specifically, and will also touch upon what the future may hold. This article is also written as a continuation of...Urinary biomarkers for surveillance of non-muscle invasive bladder cancer
Bladder cancer (BC) is the ninth most common cancer worldwide with a yearly incidence of approximately 430,000 cases. There is a male predominance and it is the seventh most common cancer in men worldwide [1]. Non-muscle invasive bladder cancer (NMIBC)...Read all about it Jan/Feb 2017
It can be awkward when a patient asks you about a report in their favourite tabloid detailing an amazing research breakthrough or a `cutting-edge’ new treatment / test and you don’t know what they are talking about! So this section...Read all about it Mar/Apr 2015
It can be awkward when a patient asks you about a report in their favourite tabloid detailing an amazing research breakthrough or a ‘cutting-edge’ new treatment / test and you don’t know what they are talking about! So this section...
Urologists beware!
This article recounts the story of a Californian urologist who was shot dead two decades later by a patient who was diagnosed with stricture of the urethra. The patient underwent surgery for urethral stricture in 1992 by a team (ironically,...
Effect of collimation on radiation dose during ureteroscopy
Over 60,000 ureteroscopies are performed annually in the UK. During these procedures radiation is used and there are concerns regarding the cumulative dose during a surgeon’s career. Common ways to minimise the dose to the theatre team are wearing lead...Men with a susceptibility to prostate cancer: implications of family history in PCa risk-prediction
Incorporation of family history (FH) status into prostate cancer (PCa) risk stratification has the potential to underpin many aspects of PCa care. This group of men presents a unique challenge in early cancer detection, particularly given that most men without...Consent Part 2
See Part 1 on this topic here Case 1 A 77 year old lady presents to the Emergency Department confused and generally unwell. She is septic and, on imaging, is found to have a 9mm obstructing right sided proximal ureteric...Benign upper tract abnormalities
Case 1 A 28-year-old lady has been referred to your clinic with right loin pain. She has no significant past medical history but mentions that she and her partner have been trying to get pregnant. She has an US renal...EAU (European Association of Urology) Talent Incubator Programme: Policy & Innovation
The randomised controlled trial (RCT) will remain one of the most important methods for medical advancements. A solid framework, an extensive network and financial resources are key factors in the success of a trial. In this module of the Talent Incubator Programme, we will address the practical side of conducting research and trials with support from policy experts, industry representatives and patient advocatesEAU (European Association of Urology) Masterclass on Focal therapy for localised prostate cancer
Focal Therapy (FT) is a promising treatment option aimed at improving the management of localised prostate cancer. This masterclass will provide you with an extensive review of the rationale for FT, the patient selection modalities and the available energy sources (HIFU, Cryo, IRE, Laser, Brachytherapy). Gain further knowledge and better understand the FT benefits.
